Details
 

August 26, 2020
5:15-7:30PM

Hematology and Oncology Board Review and Re-Certification Evening Lecture Series

GU Malignancies & Lymphoma/Myeloma

WEBINAR

MSHO is pleased to continue offering this outstanding lecture series reviewing recent data that has implications for practice. This program was originally developed for oncology fellows prior to their board review, but the outstanding faculty participation and up to the minute curriculum has evolved to make this program valuable to a wider audience. In addition to oncology and hematology fellows, attending physicians, advanced practice providers, oncology nurses, and pharmacists will find these concise reviews relevant and beneficial. Program Director, Ulka Vaishampayan, M.D., from the University of Michigan, has recruited distinguished speakers from our comprehensive cancer centers to provide the content and presentations for this update.

This session will cover:

GU Malignancie
Ulka Vaishampayan, MD
University of Michigan                                           

Lymphoma/Myeloma
Jeffrey Zonder, MD
Karmanos Cancer Institute

Series Agenda 

Click Here to Register Today!


Thank you to our webinar sponsors:

Abbvie      Amgen      AstraZeneca      Bei Gene Logo      GSK Oncology            Merck      Pfizer            Takeda Logo

For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.

Printer-Friendly Version


2020-08-26 17:15:00 2020-08-26 19:30:00 America/Detroit Hematology and Oncology Board Review and Re-Certification Evening Lecture Series MSHO is pleased to continue offering this outstanding lecture series reviewing recent data that has implications for practice. This program was originally developed for oncology fellows prior to their board review, but the outstanding faculty participation and up to the minute curriculum has evolved to make this program valuable to a wider audience. In addition to oncology and hematology fellows, attending physicians, advanced practice providers, oncology nurses, and pharmacists will find these concise reviews relevant and beneficial. Program Director, Ulka Vaishampayan, M.D., from the University of Michigan, has recruited distinguished speakers from our comprehensive cancer centers to provide the content and presentations for this update. This session will cover: GU MalignancieUlka Vaishampayan, MD University of Michigan                                            Lymphoma/MyelomaJeffrey Zonder, MD Karmanos Cancer Institute Series Agenda  Click Here to Register Today! Thank you to our webinar sponsors:                                                        For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org. WEBINAR